In 2026, Mankind Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2026 | 2025 |
|---|---|---|
Total Waste Generated | 15,266a | 14,955a |
Total Waste Recovered | 9,458a | 8,021a |
Total Hazardous Waste Generated | 1,971.99a | 1,908.77a |
Non-Hazardous Waste Disposed | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2026, Mankind Pharma generated a total of 15,266metric tonnes of waste.a
Of this amount, 61.95% of Mankind Pharma's total waste generated was recovered through methods such as recycling, reuse, or composting, while 38.31% was disposed of through landfilling, incineration, or combustion.a
In 2026, Mankind Pharma reported a total waste generation of 15,266 metric tonnes, of which 61.95% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Mankind Pharma is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2026, Mankind Pharma's total waste generation has increased by 2.08%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.a
Over the same period, Mankind Pharma's waste recovery rate increased by 15.51%.a
In 2026, Mankind Pharma generated a total of 15,266 metric tonnes of waste.a
Of this amount, 12.92% of Mankind Pharma's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.87.08% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2026, Mankind Pharma's total waste generation has increased by 2.08%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.a
Since 2026, Mankind Pharma's hazardous waste generation has increased by 1.21%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies..a
Overall, Mankind Pharma has seen a recent increase in both total waste and hazardous waste, which may indicate growing operational pressures or insufficient controls on harmful materials.a